Dr. Bethany Malone has treated a lot of colorectal cancer patients. The youngest, not counting those with genetic conditions, was 19 years old.Colorectal cancer used to be considered a cancer of older ...

Innovent Biologics has received China’s National Medical Products Administration (NMPA) approval for the New Drug Application ...

Celecoxib improves disease-free and overall survival in ctDNA-positive stage III colon cancer patients when combined with standard chemotherapy. An analysis of patients with stage III colon patients ...

During Thanksgiving 2013, Emma Dimery, then 23, experienced intense stomach cramps. After a blood test during her annual physical uncovered low hemoglobin levels, she underwent numerous tests and ...

Chaoyuan Kuang, MD, PhD, Co-Leader, GI Clinical and Translational Research, at Montefiore Einstein Comprehensive Cancer Center, and Othon Wiltz, MD, Colon and Rectal Surgeon, for Montefiore Einstein ...

Patients with stage 3 colorectal cancer who tested MRD-positive with Signatera after surgery saw a meaningful survival ...

Colorectal cancer is one of the most common cancers. Its treatment is mainly based on chemotherapy. However, over time, chemotherapy induces resistance in the majority of patients, who end up being ...

Immunotherapy uses the power of your immune system to fight your cancer. One type of immunotherapy is called an immune checkpoint inhibitor. Your immune system has built-in checkpoints that help it ...

Two years ago, Emma Dimery was told her stage 4 colon cancer was incurable. Today, she is healthy and cancer-free — and she says a last-resort clinical trial saved her life. Dimery, who lives in ...

Doctors are seeing colon cancer in people in their 20s and 30s. New research suggests it starts in infancy.

The findings are particularly relevant for India, where colorectal cancer is emerging as a growing public health concern ...